Rare diseases
Investigational molecules
Locations
237 conditions with trials, the busiest first
741 trials across Europe, recruiting first
A study testing how well cagrilintide and semaglutide help people with overweight or obesity lose weight
FranceA study testing cagrilintide and semaglutide compared to placebo in people with type 2 diabetes taking basal insulin with or without metformin
SlovakiaStudy comparing semaglutide and dapagliflozin taken separately or combined in one tablet for type 2 diabetes patients
GermanyComparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease
BulgariaStudy of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease
FranceStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
AustriaStudy of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy
DenmarkStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
BulgariaStudy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
FranceStudy of VRDN-001 compared to placebo to evaluate safety and effectiveness in adults with chronic thyroid eye disease
FranceStudy of bitopertin to improve sunlight tolerance in adults with erythropoietic protoporphyria or X-linked protoporphyria
BelgiumStudy of LY3457263 compared to placebo in adults with type 2 diabetes who are taking semaglutide or tirzepatide but have not reached their blood sugar goals
GermanyThe therapies tested most often in Metabolism and nutrition disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
